ADURO BIOTECH HOLDINGS, EUROPE B.V.
Patent Applications and Registrations
Patent applications and USPTO patent grants for ADURO BIOTECH HOLDINGS, EUROPE B.V..The latest application filed is for "anti-sirp alpha antibodies".
- ADURO BIOTECH HOLDINGS, EUROPE B.V. - OSS NL
| Patent | Date |
|---|---|
| Anti-sirp Alpha Antibodies App 20220135671 - VAN EENENNAAM; Hans ; et al. | 2022-05-05 |
| METHODS OF TREATING IgA NEPHROPATHY WITH AN APRIL BINDING ANTIBODY App 20210379183 - VAN DE LAAR; Teun ; et al. | 2021-12-09 |
| Methods For Performing Ex Vivo Diagnostic Tests For The Presence Of A Proliferation-inducing Ligand (april) In A Human Sample App 20210325404 - Van Eenennaam; Hans ; et al. | 2021-10-21 |
| Altered April Binding Antibodies App 20210221900 - Van Eenennaam; Hans ; et al. | 2021-07-22 |
| Methods for performing ex vivo diagnostic tests for the presence of a proliferation-inducing ligand (APRIL) in a human sample Grant 11,047,864 - Van Eenennaam , et al. June 29, 2 | 2021-06-29 |
| Humanized antibodies which bind to human APRIL ("a proliferation-inducing ligand") Grant 10,961,316 - van Eenennaam , et al. March 30, 2 | 2021-03-30 |
| Anti-SIRP.alpha. antibodies Grant 10,851,164 - Van Eenennaam , et al. December 1, 2 | 2020-12-01 |
| Anti-HCTLA-4 antibodies Grant 10,808,030 - Van Eenennaam , et al. October 20, 2 | 2020-10-20 |
| Altered April Binding Antibodies App 20200079859 - van Eenennaam; Hans ; et al. | 2020-03-12 |
| Anti-PD-1 antibodies Grant 10,494,436 - Van Eenennaam , et al. De | 2019-12-03 |
| Method of treating IgA nephropathy by administering humanized APRIL-binding antibodies Grant 10,377,830 - van Eenennaam , et al. A | 2019-08-13 |
| Method For Obtaining April-binding Peptides, Process For Producing The Peptides, April-binding Peptides Obtainable With Said Met App 20190170766 - Van Eenennaam; Hans ; et al. | 2019-06-06 |
| Combining Cd27 Agonists And Immune Checkpoint Inhibition For Immune Stimulation App 20190135933 - Van Eenennaam; Hans ; et al. | 2019-05-09 |
| Anti-sirp Alpha Antibodies App 20180312587 - VAN EENENNAAM; Hans ; et al. | 2018-11-01 |
| Proliferation-inducing ligand (APRIL)-binding peptides Grant 10,107,821 - Van Eenennaam , et al. October 23, 2 | 2018-10-23 |
| Altered April Binding Antibodies App 20180258176 - van Eenennaam; Hans ; et al. | 2018-09-13 |
| Altered APRIL binding antibodies Grant 9,969,808 - van Eenennaam , et al. May 15, 2 | 2018-05-15 |
| New Anti-hctla-4 Antibodies App 20180037654 - VAN EENENNAAM; Hans ; et al. | 2018-02-08 |
| Anti-pd-1 Antibodies App 20180030137 - VAN EENENNAAM; Hans ; et al. | 2018-02-01 |
| Agonistic Antibody To Cd27 App 20170267771 - VAN EENENNAAM; Hans ; et al. | 2017-09-21 |
| Agonistic antibody to CD27 Grant 9,527,916 - Van Eenennaam , et al. December 27, 2 | 2016-12-27 |
| Altered April Binding Antibodies App 20160264674 - van Eenennaam; Hans ; et al. | 2016-09-15 |
| Method For Obtaining April-binding Peptides, Process For Producing The Peptides, April-binding Peptides Obtainable With Said Method/process And Use Of The April-binding Peptides App 20160202267 - VAN EENENNAAM; Hans ; et al. | 2016-07-14 |
| Cd70-binding Peptides And Method, Process And Use Relating Thereto App 20160194402 - VAN EENENNAAM; Hans ; et al. | 2016-07-07 |
| Combining Cd27 Agonists And Immune Checkpoint Inhibition For Immune Stimulation App 20160185870 - VAN EENENNAAM; Hans ; et al. | 2016-06-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 